Last week, Target Corp. (TGT) offered a rather gruesome outlook for 2017 that came on the heels of a very weak Q4 2016 performance. Much of the Q4 results were offered in a prelimi...
Shares of Seattle Genetics (SGEN), a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer, are in focus in morning tradin...
The Habit Restaurants, Inc. (HABT), a fast casual restaurants company yesterday reported fourth quarter and full year 2016 financial results. Habit reported fourth quarter earnings...
The FDA, which gave its nod to 22 treatments last year, has given its approval to 5 drugs so far in 2017. This includes Synergy’s Trulance (treatment of chronic idiopathic consti...
Good day to all and happy week ahead. To summarize we are at an important junction and the important levels to watch out for at 102.30 and 100.70. Don’t forget the possible Head ...
Written by Isabelle Mateos y Lago China’s debt-driven growth model is starting to reach its limits yet the country is also transitioning into a high-tech, more consumer-driven e...
Merkel in the running for a fourth term as Chancellor of Germany. There are no term limits. However, in the past, Merkel was criticalof her predecessor and mentor Kohl for outs...
With the disclaimer being that as an intuitive and more artful TA using inter-market ratio measuring tools and the like, I am the furthest thing from an accomplished cycles analyst...
Every once in a while, I like to check in and see how these stocks are performing. For the most part, these names have held up quite well. In fact, all four names are within spitti...
With Millennials piling in and Barrons bashing it, Snap Inc’s shares have plunged this morning after opening up over 4%. The stock is now down 14% from its spike highs on ...